ReShape Lifesciences Inc. (RSLS)

Name: ReShape Lifesciences Inc. (RSLS) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: ReShape Lifesciences Inc. (RSLS)

Stock Card

$3.92

$-8.88 (-69.38%)

As on 14-Aug-2025 16:28EDT

Market cap

$9 Mln

Revenue (TTM)

$6 Mln

P/E Ratio

P/B Ratio

30.4

Div. Yield

0 %

ReShape Lifesciences (RSLS) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 2.80 High: 4.65

52 Week Range

Low: -- High: --

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-1.2 %
ROCE

-- %
Industry P/E

44.46
EV/EBITDA

-0
Debt to Equity

0
Book Value

$--
EPS

$-127.8
Face value

--
Shares outstanding

2,385,960

10 Years Aggregate

CFO

$-191.71 Mln

EBITDA

$-226.79 Mln

Net Profit

$-405.33 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
ReShape Lifesciences (RSLS)	-99.1	-58.8	-84.3	-99.6	-96.9	-91.1	-73.2
BSE Sensex^*	-10.1	-2.5	2.0	-5.0	5.2	5.7	10.3
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 14-Aug-2025 | *As on 03-Sep-2026 | #As on 26-Oct-2023

Company	2024	2023	2022	2021	2020	2019	2018
ReShape Lifesciences (RSLS)	-68.8	-96.3	-91.8	-53.8	-38.3	125.5	-82.6
S&P Small-Cap 600	7.0	13.9	-17.4	25.3	9.6	20.9	-9.7
BSE Sensex	8.1	18.7	4.4	22.0	15.8	14.4	5.9

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Shareholding Pattern

View Details

About ReShape Lifesciences (RSLS)

As of August 14, 2025, ReShape Lifesciences Inc. was acquired by Vyome Therapeutics Inc., in a reverse merger transaction. ReShape Lifesciences Inc. provides products and services that manage and treat obesity and metabolic diseases in the United... States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System to treat obesity and invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus. It is involved in the development of the ReShape Obalon Balloon System, which consists of a swallowable capsule that tracks and displays the location of the balloon during placement; and the Diabetes Bloc-Stim Neuromodulation (DBSN) device, a technology that is in development for the treatment of type 2 diabetes mellitus. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in Irvine, California. Read more

Executive Chair

Mr. Dan W. Gladney
Executive Chair

Mr. Dan W. Gladney
Headquarters

Irvine, CA
Website

https://www.reshapelifesciences.com

FAQs for ReShape Lifesciences (RSLS)

What is the current share price of ReShape Lifesciences Inc (RSLS) Today?

The share price of ReShape Lifesciences Inc (RSLS) is $3.92 (NASDAQ) as of 14-Aug-2025 16:28 EDT. ReShape Lifesciences Inc (RSLS) has given a return of -96.93% in the last 3 years.

What is the current PB & PE ratio of ReShape Lifesciences Inc (RSLS)?

Since, TTM earnings of ReShape Lifesciences Inc (RSLS) is negative, P/E ratio is not available.
The P/B ratio of ReShape Lifesciences Inc (RSLS) is 30.42 times as on 14-Aug-2025, a 703 premium to its peers’ median range of 3.79 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2024	-0.02	-0.52
2023	-0.01	0.02
2022	-0.08	0.96
2021	-0.47	0.65
2020	-0.01	0.01

What is the 52 Week High and Low of ReShape Lifesciences Inc (RSLS)?

The 52-week high and low of ReShape Lifesciences Inc (RSLS) are Rs -- and Rs -- as of 03-Sep-2026.

What is the market cap of ReShape Lifesciences Inc (RSLS)?

ReShape Lifesciences Inc (RSLS) has a market capitalisation of $ 9 Mln as on 14-Aug-2025. As per SEBI classification, it is a Small Cap company.

Should I invest in ReShape Lifesciences Inc (RSLS)?

Before investing in ReShape Lifesciences Inc (RSLS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.